Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
ACS Chem Neurosci ; 12(12): 2143-2150, 2021 06 16.
Article in English | MEDLINE | ID: covidwho-1260918

ABSTRACT

The recent coronavirus disease of 2019 (COVID-19) pandemic has adversely affected people worldwide. A growing body of literature suggests the neurological complications and manifestations in response to COVID-19 infection. Herein, we explored the inflammatory and immune responses in the post-mortem cerebral cortex of patients with severe COVID-19. The participants comprised three patients diagnosed with severe COVID-19 from March 26, 2020, to April 17, 2020, and three control patients. Our findings demonstrated a surge in the number of reactive astrocytes and activated microglia, as well as low levels of glutathione along with the upregulation of inflammation- and immune-related genes IL1B, IL6, IFITM, MX1, and OAS2 in the COVID-19 group. Overall, the data imply that oxidative stress may invoke a glial-mediated neuroinflammation, which ultimately leads to neuronal cell death in the cerebral cortex of COVID-19 patients.


Subject(s)
COVID-19 , Cell Death , Cerebral Cortex , Humans , Pandemics , SARS-CoV-2
2.
ACS Chem Neurosci ; 11(13): 1909-1913, 2020 07 01.
Article in English | MEDLINE | ID: covidwho-595643

ABSTRACT

Studies have found increased rates of dysosmia in patients with Novel Coronavirus disease 2019 (COVID-19). However, the mechanism that causes olfactory loss is unknown. The primary objective of this study was to explore local proinflammatory cytokine levels in the olfactory epithelium in patients with COVID-19. Biopsies of the olfactory epithelium were taken from patients with confirmed COVID-19 as well as uninfected controls. Levels of tumor necrosis factor α (TNF-α) and interleukin-1-beta (IL-1ß) were assessed using ELISA and compared between groups. Average TNF-α levels were significantly increased in the olfactory epithelium of the COVID-19 group compared to the control group (P < 0.05). However, no differences in IL-1ß were seen between groups. Elevated levels of the proinflammatory cytokine TNF-α were seen in the olfactory epithelium in patients with COVID-19. This suggests that direct inflammation of the olfactory epithelium could play a role in the acute olfactory loss described in many patients with COVID-19.


Subject(s)
Betacoronavirus , Coronavirus Infections/metabolism , Cytokines/metabolism , Olfaction Disorders/metabolism , Olfactory Mucosa/metabolism , Pneumonia, Viral/metabolism , Adult , COVID-19 , Coronavirus Infections/complications , Coronavirus Infections/diagnosis , Cytokines/analysis , Female , Humans , Male , Middle Aged , Olfaction Disorders/diagnosis , Olfaction Disorders/etiology , Pandemics , Pneumonia, Viral/complications , Pneumonia, Viral/diagnosis , SARS-CoV-2 , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL